MX2021006863A - Composiciones que comprenden cepas bacterianas de parabacteroides para tratar el cancer. - Google Patents
Composiciones que comprenden cepas bacterianas de parabacteroides para tratar el cancer.Info
- Publication number
- MX2021006863A MX2021006863A MX2021006863A MX2021006863A MX2021006863A MX 2021006863 A MX2021006863 A MX 2021006863A MX 2021006863 A MX2021006863 A MX 2021006863A MX 2021006863 A MX2021006863 A MX 2021006863A MX 2021006863 A MX2021006863 A MX 2021006863A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- treating cancer
- bacterial strains
- parabacteroides
- parabacteroides bacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La invención proporciona una composición que comprende una cepa bacteriana del género Parabacteroides, para su uso en un método para tratar o prevenir el cáncer en un sujeto, donde el cáncer comprende la señalización de ERK oncogénica.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18212087 | 2018-12-12 | ||
PCT/EP2019/080131 WO2020089488A1 (en) | 2018-11-02 | 2019-11-04 | Compositions comprising bacterial strains |
GBGB1916001.9A GB201916001D0 (en) | 2019-11-04 | 2019-11-04 | Compositions comprising bacterial strains |
PCT/EP2019/084994 WO2020120717A1 (en) | 2018-12-12 | 2019-12-12 | Compositions comprising parabacteroides bacterial strains for treating cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2021006863A true MX2021006863A (es) | 2021-09-14 |
Family
ID=71075994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2021006863A MX2021006863A (es) | 2018-12-12 | 2019-12-12 | Composiciones que comprenden cepas bacterianas de parabacteroides para tratar el cancer. |
Country Status (15)
Country | Link |
---|---|
US (1) | US11446336B2 (es) |
EP (1) | EP3876964A1 (es) |
JP (1) | JP2022513208A (es) |
KR (1) | KR20210102311A (es) |
CN (1) | CN113207282A (es) |
AU (1) | AU2019396657A1 (es) |
BR (1) | BR112021010917A2 (es) |
CA (1) | CA3122347A1 (es) |
EA (1) | EA202191631A1 (es) |
IL (1) | IL283851A (es) |
MA (1) | MA54161A (es) |
MX (1) | MX2021006863A (es) |
SG (1) | SG11202106258YA (es) |
TW (1) | TW202038978A (es) |
WO (1) | WO2020120717A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114025794A (zh) * | 2018-11-02 | 2022-02-08 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
CN113559275B (zh) * | 2021-09-24 | 2021-12-24 | 广东粤港澳大湾区国家纳米科技创新研究院 | 一种一锅法制备高分子/康普瑞汀a4/blz945纳米键合药的方法 |
CN114588182B (zh) * | 2021-12-28 | 2023-09-01 | 南京医科大学 | 植物乳杆菌l168辅助索拉非尼治疗肝癌的用途 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
GB0526033D0 (en) | 2005-12-21 | 2006-02-01 | Bioeos Ltd | Method |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
US20180078587A1 (en) | 2015-03-18 | 2018-03-22 | Trustees Of Tufts College | Compositions and methods for preventing colorectal cancer |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
AU2017234120B2 (en) | 2016-03-14 | 2024-06-20 | Holobiome, Inc. | Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system |
EP3541400A2 (en) | 2016-11-18 | 2019-09-25 | Sanford Burnham Prebys Medical Discovery Institute | Gut microbiota and treatment of cancer |
WO2018112365A2 (en) * | 2016-12-16 | 2018-06-21 | Evelo Biosciences, Inc. | Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii |
WO2018112363A1 (en) * | 2016-12-16 | 2018-06-21 | Evelo Biosciences, Inc. | Methods of treating cancer using parabacteroides |
CN110191946A (zh) | 2016-12-23 | 2019-08-30 | 学校法人庆应义塾 | 诱导cd8+t细胞的组合物及方法 |
BR112019028301A2 (pt) | 2017-07-05 | 2020-07-14 | Evelo Biosciences, Inc. | composições e métodos para tratar câncer com o uso de bifidobacterium animalis ssp. lactis |
-
2019
- 2019-12-12 TW TW108145620A patent/TW202038978A/zh unknown
- 2019-12-12 EP EP19829463.9A patent/EP3876964A1/en not_active Withdrawn
- 2019-12-12 JP JP2021533441A patent/JP2022513208A/ja active Pending
- 2019-12-12 CN CN201980081809.2A patent/CN113207282A/zh active Pending
- 2019-12-12 CA CA3122347A patent/CA3122347A1/en active Pending
- 2019-12-12 MX MX2021006863A patent/MX2021006863A/es unknown
- 2019-12-12 EA EA202191631A patent/EA202191631A1/ru unknown
- 2019-12-12 MA MA054161A patent/MA54161A/fr unknown
- 2019-12-12 KR KR1020217020949A patent/KR20210102311A/ko unknown
- 2019-12-12 WO PCT/EP2019/084994 patent/WO2020120717A1/en active Search and Examination
- 2019-12-12 AU AU2019396657A patent/AU2019396657A1/en not_active Abandoned
- 2019-12-12 SG SG11202106258YA patent/SG11202106258YA/en unknown
- 2019-12-12 BR BR112021010917-0A patent/BR112021010917A2/pt not_active Application Discontinuation
-
2021
- 2021-05-20 US US17/325,502 patent/US11446336B2/en active Active
- 2021-06-09 IL IL283851A patent/IL283851A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2019396657A1 (en) | 2021-07-08 |
CN113207282A (zh) | 2021-08-03 |
SG11202106258YA (en) | 2021-07-29 |
CA3122347A1 (en) | 2020-06-18 |
JP2022513208A (ja) | 2022-02-07 |
TW202038978A (zh) | 2020-11-01 |
US20210283194A1 (en) | 2021-09-16 |
KR20210102311A (ko) | 2021-08-19 |
BR112021010917A2 (pt) | 2021-08-31 |
IL283851A (en) | 2021-07-29 |
WO2020120717A1 (en) | 2020-06-18 |
US11446336B2 (en) | 2022-09-20 |
MA54161A (fr) | 2022-03-23 |
EA202191631A1 (ru) | 2021-09-03 |
EP3876964A1 (en) | 2021-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021000710A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2020009455A (es) | Composiciones que comprenden cepas bacterianas. | |
NZ749872A (en) | Compositions comprising bacterial strains | |
AU2019264537A1 (en) | Beta-lactamase inhibitors | |
SA517390513B1 (ar) | تركيبات تشتمل على سلالات بكتيرية | |
MX2020005772A (es) | Composiciones que comprenden cepas bacterianas. | |
WO2020120714A8 (en) | Compositions comprising bacterial strains | |
MX2017011630A (es) | Composiciones y metodos para tratar rosacea y acne. | |
MD3209381T2 (ro) | Compoziții care conțin tulpini bacteriene | |
EP3750907A3 (en) | Raav-based compositions and methods for treating amyotrophic lateral sclerosis | |
MX2016014807A (es) | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. | |
MX2021006863A (es) | Composiciones que comprenden cepas bacterianas de parabacteroides para tratar el cancer. | |
CY1125211T1 (el) | Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη | |
MX2022007775A (es) | Composición para usarse en terapia de microbiota. | |
MX2019010492A (es) | Kits y metodos para preparar composiciones de plaquetas con patogeno inactivado. | |
MX2020004118A (es) | Composiciones y metodos para tratar enfermedades de liberibacter y otras enfermedades bacterianas. | |
MX2018004274A (es) | Metodos y composiciones para contracciones musculares no deseadas o anormales. | |
IL281951A (en) | compounds containing bacterial strains | |
WO2019078698A3 (ko) | 항 -msln항체 및 이를포함하는 암치료용 약학적 조성물 | |
IL280895A (en) | compounds containing bacterial strains | |
WO2018081817A3 (en) | Targeting microrna-101-3p in cancer therapy | |
MX2021003598A (es) | Microorganismos para la inhibicion de patogenos vegetales. | |
MX2019009200A (es) | Composiciones y métodos para inhibir el reticulón 4. | |
MX2021013908A (es) | Tratamiento para el cáncer. | |
WO2018183219A3 (en) | Nucleic acid-based compositions and methods for treating small vessel diseases |